Galera Therapeutics Seeks Strategic Alternatives Amid Financial Setbacks and Regulatory Challenges

22d ago, source: MyChesCo on MSN

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a key player in the pharmaceutical industry, recently unveiled its ...

Galera Therapeutics, Inc.

8mon ago, source: CNN

Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved ...

Why Is Cancer Focused Galera Therapeutics Stock Sinking Today?

5mon ago, source: Hosted on MSN

Galera Therapeutics Inc (NASDAQ: GRTX) received official meeting minutes from the Type A meeting with the FDA held last month. The FDA reiterated the need for an additional Phase 3 trial of ...

Galera Therapeutics Inc (GRTX) Stock Records -19.32% Quarterly Movement

6d ago, source: newsheater

The stock of Galera Therapeutics Inc (GRTX) has gone up by 4.62% for the week, with a -19.51% drop in the past month and a -19.32% drop in the past quarter. The volatility ratio for the week is 7.87%, ...

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

26d ago, source: Business Insider

MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have ...

Galera Therapeutics Inc Ordinary Shares

20d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Galera (GRTX) Earnings Dates & Reports

27d ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

GRTX Galera Therapeutics, Inc.

1mon ago, source: Seeking Alpha

The security has traded for less than one year There is no Wall Street analyst coverage The security is a closed-end fund or a mortgage REIT The security is listed on a non-US exchange The ...

Galera Therapeutics: Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

26d ago, source: Finanznachrichten

MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have ...

Galera Therapeutics Inc (GRTX)

1mon ago, source: Investing

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.